Laboratorios Rovi (ROVI.MC): analysis and statistics
Return, volatility, Sharpe ratio and risk for Laboratorios Rovi, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $59.25 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +14.26% |
| Total return over period | +49.88% |
| Annualized volatility | 30.61% |
| Sharpe ratio | 0.35 |
| Sortino ratio | 0.44 |
| Max drawdown | -48.16% |
| CVaR 95% (avg. loss, worst 5% of days) | -4.94% |
| Correlation with the S&P 500 | 0.07 |
| Period range | $41.65 – $87.28 |
| Trading days analyzed | 765 |
Over the last 3.0 years, Laboratorios Rovi (ROVI.MC) has posted an annualized return of +14.26% with annual volatility of 30.61%, a Sharpe ratio of 0.35. Its worst stretch (max drawdown from a peak) was -48.16%. Its correlation with the S&P 500 is 0.07, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how ROVI.MC would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with ROVI.MC →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio